BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 22, 2004
View Archived Issues
Statins reported to reduce blood pressure in nonhypertensive subjects
Read More
Pioglitazone improves insulin resistance and carotid IMT in type 2 diabetes
Read More
Clinical assessment of ABX-10241 in secondary hyperparathyroidism begins
Read More
TGN-255 investigated in two phase I studies
Read More
Encouraging phase I findings for DNA influenza vaccine
Read More
Phase II results from Altastaph neonate study
Read More
Restructuring at Tapestry
Read More
Viventia enhances phase I bladder cancer program for Proxinium
Read More
Xagrid approved in E.U.
Read More
Azilect recommended for approval in Europe
Read More
New NCI-sponsored study of GTI-2040 for prostate cancer
Read More
ISTA licenses U.S. rights for ecabet sodium for dry eye
Read More
Dosing commences in phase I study of LEraf-AON
Read More
Promising safety profile of a peginterferon/ribavirin/amantadine regimen in HIV/HCV coinfection
Read More
Positive opinion for Truvada in Europe
Read More
New orexin receptor antagonists claimed by Actelion
Read More
Melatonin derivatives for the treatment of neurological diseases
Read More
Roche researchers describe receptor tyrosine kinase inhibitors
Read More
New protein kinase inhibitors prepared and tested at Roche
Read More
Novel TPK1 inhibitors and their use in neurodegenerative diseases covered in patent
Read More
Raf-kinase inhibitors in early development at Merck
Read More
A topical gel containing rAAT shows a good tolerability profile in patients with atopic dermatitis
Read More
Emisphere signs agreement with Roche to develop oral formulations of compounds for bone diseases
Read More
IDEA-070 reduces inflammation and pain in UVB-induced sunburn
Read More
Update on the antitumor efficacy and safety of BAY-43-9006
Read More
HepeX-C development progresses
Read More
Symbollon receives Canadian authorities' guidance for IoGen
Read More
Tarceva approved for advanced NSCLC
Read More
Further data supporting link between Lp-PLA2 and risk of cardiovascular disease
Read More
